Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Maskell

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
The Lancet Regional Health. Europe|December 12, 2022
Effectiveness of BNT162b2 COVID-19 vaccination in prevention of hospitalisations and severe disease in adults with SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variant between June 2021 and July 2022: A prospective test negative case-control studyAnastasia Chatzilena, Catherine Hyams, Rob Challen, et al.
Breathe (Sheffield, England)|January 24, 2024
The European Respiratory Society led training programme improves self-reported competency and increases the use of thoracic ultrasoundPia Iben Pietersen, Lars Konge, Rahul Bhatnagar, et al.
Chest|June 13, 2021
The Association Between Pleural Fluid Exposure and Survival in Pleural MesotheliomaRachelle Asciak, Nikolaos I Kanellakis, Anna Bibby, et al.
Annals of the American Thoracic Society|March 22, 2017
Dose De-escalation of Intrapleural Tissue Plasminogen Activator Therapy for Pleural Infection. The Alteplase Dose Assessment for Pleural Infection Therapy ProjectNatalia Popowicz, Oliver Bintcliffe, Duneesha De Fonseka, et al.
BMJ Open Respiratory Research|December 10, 2025
Determinants of respiratory tract aerosol generation in a diverse clinical population: an observational studyGeorge W Nava, Alicja Szczepanska, Liji Ng, et al.
Trials|September 21, 2014
A multicentre non-blinded randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma (RESPECT-MESO): study protocol for a randomised controlled trialSamal Gunatilake, Fraser J H Brims, Carole Fogg, et al.
BMJ Open Respiratory Research|May 16, 2025
Emergency department presentations of community-acquired lower respiratory tract disease in Bristol, UK: a prospective cohort study 2022-2023Catherine Hyams, Robert Challen, Maria Lahuerta, et al.
Breathe (Sheffield, England)|July 26, 2023
Evidence-based training and certification: the ERS thoracic ultrasound training programmePia Iben Pietersen, Rahul Bhatnagar, Najib M Rahman, et al.
BMJ Open Respiratory Research|December 10, 2025
First-line medical thoracoscopy for pleural infection: the SPIRIT randomised controlled feasibility trialKrishan Ragab Bansal, David T Arnold, Emma Tucker, et al.
BMC Infectious Diseases|August 21, 2025
Improving the accuracy of Respiratory Syncytial Virus (RSV) incidence estimates among hospitalised adults in Bristol, UKKatie Lihou, Robert Challen, Anastasia Chatzilena, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
The Lancet Regional Health. Europe|December 12, 2022
Effectiveness of BNT162b2 COVID-19 vaccination in prevention of hospitalisations and severe disease in adults with SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variant between June 2021 and July 2022: A prospective test negative case-control studyAnastasia Chatzilena, Catherine Hyams, Rob Challen, et al.
Breathe (Sheffield, England)|January 24, 2024
The European Respiratory Society led training programme improves self-reported competency and increases the use of thoracic ultrasoundPia Iben Pietersen, Lars Konge, Rahul Bhatnagar, et al.
Chest|June 13, 2021
The Association Between Pleural Fluid Exposure and Survival in Pleural MesotheliomaRachelle Asciak, Nikolaos I Kanellakis, Anna Bibby, et al.
Annals of the American Thoracic Society|March 22, 2017
Dose De-escalation of Intrapleural Tissue Plasminogen Activator Therapy for Pleural Infection. The Alteplase Dose Assessment for Pleural Infection Therapy ProjectNatalia Popowicz, Oliver Bintcliffe, Duneesha De Fonseka, et al.
BMJ Open Respiratory Research|December 10, 2025
Determinants of respiratory tract aerosol generation in a diverse clinical population: an observational studyGeorge W Nava, Alicja Szczepanska, Liji Ng, et al.
Trials|September 21, 2014
A multicentre non-blinded randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma (RESPECT-MESO): study protocol for a randomised controlled trialSamal Gunatilake, Fraser J H Brims, Carole Fogg, et al.
BMJ Open Respiratory Research|May 16, 2025
Emergency department presentations of community-acquired lower respiratory tract disease in Bristol, UK: a prospective cohort study 2022-2023Catherine Hyams, Robert Challen, Maria Lahuerta, et al.
Breathe (Sheffield, England)|July 26, 2023
Evidence-based training and certification: the ERS thoracic ultrasound training programmePia Iben Pietersen, Rahul Bhatnagar, Najib M Rahman, et al.
BMJ Open Respiratory Research|December 10, 2025
First-line medical thoracoscopy for pleural infection: the SPIRIT randomised controlled feasibility trialKrishan Ragab Bansal, David T Arnold, Emma Tucker, et al.
BMC Infectious Diseases|August 21, 2025
Improving the accuracy of Respiratory Syncytial Virus (RSV) incidence estimates among hospitalised adults in Bristol, UKKatie Lihou, Robert Challen, Anastasia Chatzilena, et al.
Pageof 7